Introgen Therapeutics INC
SEC CIK 1018710 · ingn · last insider filing 2009-02-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gillis Stephen Malcolm | Director | filed 2006 - 2009 |
| Rothman James | Director | filed 2008 - 2008 |
| Kapoor John N | Director | filed 2006 - 2008 |
| Hutt Peter Barton | Director | filed 2006 - 2008 |
| Cunningham William H DR | Director | filed 2006 - 2008 |
| Long Charles E | Director | filed 2006 - 2008 |
| Pearson Robert W. | Director | filed 2008 - 2008 |
| Nance David G | Director · Chief Executive Officer & Pres | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Albrecht James W JR | Chief Financial Officer | filed 2006 - 2008 |
| Talbott MAX W | St. Vice President | filed 2006 - 2008 |
| Parker David L | Vice President | filed 2006 - 2008 |
| Enloe J David JR | Sr. Vice President | filed 2006 - 2008 |
| Sobol Robert E | Sr. Vice President | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.